
Dementia-related Psychosis Market Set for 26% Growth Through 2036
The market for dementia-related psychosis treatments is projected to reach a significant expansion phase between 2026 and 2036, driven by a growing global patient population and a pipeline of novel pharmacological interventions aimed at addressing hallucinations and delusions in neurodegenerative conditions.
























